|
|
||||||||
From the Department of Neurology (Drs. Jagust, Friedland, and Koss), School of Medicine, University of California, Davis; Veterans Administration Medical Center (Drs. Jagust, Friedland, Koss, and Ober), Martinez, CA; Donner Laboratory (Drs. Jagust, Friedland, and Budinger), University of California, Berkeley; Veterans Administration Medical Center (Dr. Ober), Livermore, CA; and Laboratory of Neurosciences (Drs. Friedland and Koss), National Institute on Aging, NIH, Betbeada, MD.
Measurement of cerebral glucose metabolism in six patients with Alzheimer's disease using positron emission tomography demonstrated that hypometabolism remained relatively more severe in parietal cortex than in frontal cortex over time. Lateral metabolic asymmetries were preserved in less severely involved brain regions, but were less stable in parietal cortex.
Address correspondence and reprint requests to Dr. Jagust, Department of Neurology (127), Veterans Administration Medical Center, 150 Muir Road, Martinez, CA 94553.
Supported by NIH grant AG05890 from the National Institute on Aging, by the Medical Research Service of the United States Veterans Administration, and by the Director, Office of Energy Research, Office of Health and Environmental Research of the United States Department of Energy under contract DE-AC03-76SF00098.
Presented in part at the thirty-ninth annual meeting of the American Academy of Neurology, New York, NY, April 1987.
Received June 16, 1987. Accepted for publication in final form October 23, 1987.
This article has been cited by other articles:
![]() |
K HERHOLZ, S F CARTER, and M JONES Positron emission tomography imaging in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S160 - S167. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hirono, M. Hashimoto, K. Ishii, H. Kazui, and E. Mori One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 488 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, K. Murase, N. Oku, M. Imaizumi, M. Takasawa, P. Rishu, Y. Kimura, Y. Ikejiri, K. Kitagawa, M. Hori, et al. Heterogeneity of Cerebral Blood Flow in Alzheimer Disease and Vascular Dementia AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1341 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Grady, A. R. McIntosh, S. Beig, M. L. Keightley, H. Burian, and S. E. Black Evidence from Functional Neuroimaging of a Compensatory Prefrontal Network in Alzheimer's Disease J. Neurosci., February 1, 2003; 23(3): 986 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Alexander, K. Chen, P. Pietrini, S. I. Rapoport, and E. M. Reiman Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies Am J Psychiatry, May 1, 2002; 159(5): 738 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Grady, M. L. Furey, P. Pietrini, B. Horwitz, and S. I. Rapoport Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease Brain, April 1, 2001; 124(4): 739 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
B TOONE Cerebral dysfunction and psychotic symptoms in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 148 - 149. [Full Text] |
||||
![]() |
M. J. de Leon, T. McRae, H. Rusinek, A. Convit, S. De Santi, C. Tarshish, J. Golomb, N. Volkow, K. Daisley, N. Orentreich, et al. Cortisol Reduces Hippocampal Glucose Metabolism in Normal Elderly, but Not in Alzheimer's Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3251 - 3259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |